Financials
Financial year 2025
PHARMACIE VAN ELEWYCK from Sint-Gillis (bij-Brussel), company number BE0870807503, closed financial year 2025 with a result of € -25,770 after tax. For that financial year PHARMACIE VAN ELEWYCK recorded a gross margin of € 55,199 and equity of € 65,980. Compared with financial year 2024, the result moved from € 28,261 to € -25,770. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 65,980
▼ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -25,770
▼ still € 28,261 profit in 2024
Profit after tax over the fiscal year.
€ 22,440
▼ 60% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 59,780.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 72,728
▲ 16% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,105
▲ 19% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2,937
▲ 17% vs 2024
Loans from banks and other lenders, long and short.
€ 146,222
▲ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 307
▼ 98% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 104,075 | € 87,853 | € 111,254 | € 55,199 | ▼ 50% |
| Profit after taxes | € 34,889 | € 18,966 | € 28,261 | € -25,770 | ▼ € 54,032 |
| Equity | € 47,523 | € 63,489 | € 91,750 | € 65,980 | ▼ 28% |
| Total debts | € 154,055 | € 162,256 | € 150,265 | € 149,466 | ▼ 1% |
| Cash | € 55,749 | € 57,658 | € 55,890 | € 22,440 | ▼ 60% |
| Retained profit | € 41,323 | € 57,289 | € 85,550 | € 59,780 | ▼ 30% |
| Dividend | € 20,000 | € 3,000 | € 0 | € 0 | |
| Bank debt | € 12,546 | € 7,302 | € 2,507 | € 2,937 | ▲ 17% |
| Balance sheet total | € 201,579 | € 225,745 | € 242,015 | € 215,446 | ▼ 11% |
| Employees (FTE) | 0.9 | 0.9 | 1.1 | - |
Key figures of PHARMACIE VAN ELEWYCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE VAN ELEWYCK?
What happened at PHARMACIE VAN ELEWYCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 25,770 (▼ € 54,032 vs 2024). filed late Source: NBB ↗
- New establishment in Sint-Gillis (bij-Brussel). KBO
- Start of the company according to the CBE. KBO
In short
From € 34,889 profit in 2022 to € 25,770 loss in 2025.
Paid € 26,570 in corporate taxes since 2022.
Best year ever: 2022, with € 34,889 profit.
On average € 101,100 of value added per employee in 2024.
A new publication or filing at PHARMACIE VAN ELEWYCK? We notify you, reason included.
Follow PHARMACIE VAN ELEWYCKDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE VAN ELEWYCK is Quentin Fozing Sontia Ghislain.
Directors
According to the 2025 annual accounts
Quentin Fozing Sontia Ghislain
Director
Establishments
Establishment units
Physical locations of this company
Antoine Bréartstraat 4
1060 Sint-Gillis (bij-Brussel)
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0870.807.503
- VAT number
- BE 0870.807.503
- Registered office
- Antoine Bréartstraat 4, 1060 Sint-Gillis (bij-Brussel)
- Names & denominations
- PHARMACIE VAN ELEWYCK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 2004
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers